Skip to Main Content

Paper Details

Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors.
Neuroendocrinology
4
2022
Author NameAffiliation
Guido SauterInstitute for Pathology, University Medical Center Hamburg-Eppendorf
  • 1 - 1

Datasets

Release 1.2